James Corbett was last confirmed as CEO and Board Member at AVITA Medical, Inc. (RCEL) in a filing dated April 22, 2025. AVITA Medical, Inc. reported in an 8-K filed June 5, 2025 that James Corbett was appointed Director, effective June 4, 2025. AVITA Medical, Inc. reported in an 8-K filed September 30, 2022 that James Corbett was appointed President and CEO, effective September 28, 2022. The proxy statement of AVITA Medical, Inc. reports total compensation of $1,407,715 for James Corbett in fiscal 2025, including a base salary of $569,302. Disclosed compensation is on record for 5 fiscal years. James Corbett has spoken on 3 earnings calls across 1 company, most recently for AVITA Medical, Inc. on April 11, 2024. The companies whose calls James Corbett spoke on are classified in the Healthcare sector.
“All seven directors named in the Proxy Statement were elected to serve on the Company's Board of Directors with the following vote:”
AVITA Medical, Inc. Form 8-K, filed June 5, 2025
· Read the filing
“Effective September 28, 2022, the Board of Directors of the Company appointed James Corbett as the Company's President and CEO.”
AVITA Medical, Inc. Form 8-K, filed September 30, 2022
· Read the filing
James Corbett on recent calls
“I will begin today's call by discussing our financial and business results for the first quarter, followed by our priorities and outlook for 2024.”
“I will begin today's call by discussing highlights of the second quarter, followed by an update on 2023 priorities. Following this update, you will hear commentary on our financial performance from our new CFO, David O'Toole.”
